Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SELECTIS HEALTH, INC.GBCS · Entity 9641 | CFO | July 09, 2021 | July 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SELECTIS HEALTH, INC.
Report date July 09, 2021 · Filed July 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2021-07-09 transaction · row 1
1 source rowRow 1 · 2021-07-09 · Purchase · Acquired 20,000 · Balance 20,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2021 Filed Jul 13, 2021 18:36 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | PurchaseCommon Stock | 20,000 | $0.50 | $10,000.00 |
DisclosureSEC source: 0001493152-21-016705 · ownership.xml · nonDerivative · entry 1 Thall Brandon · CIK 0001835607 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.